Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001504412-11-000118
Filing Date
2011-10-24
Accepted
2011-10-24 13:55:25
Documents
11
Period of Report
2011-05-31

Document Format Files

Seq Description Document Type Size
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION grace25312011_10kz.htm 10-K/A 26658
2 EXHIBIT 31 f10ka_ex31z1.htm EX-31.1 6585
3 EXHIBIT 31 f10ka_ex31z2.htm EX-31.2 6542
4 EXHIBIT 32 f10ka_ex32z1.htm EX-32.1 3234
5 EXHIBIT 32 f10ka_ex32z2.htm EX-32.2 3156
  Complete submission text file 0001504412-11-000118.txt   682718

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT g2i-20110531.xml EX-101.INS 65192
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT g2i-20110531_cal.xml EX-101.CAL 4586
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT g2i-20110531_def.xml EX-101.DEF 41410
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT g2i-20110531_lab.xml EX-101.LAB 75780
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT g2i-20110531_pre.xml EX-101.PRE 56029
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT g2i-20110531.xsd EX-101.SCH 7767
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Grace 2, Inc. (Filer) CIK: 0001366541 (see all company filings)

EIN.: 203708500 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K/A | Act: 34 | File No.: 000-52062 | Film No.: 111154171
SIC: 2834 Pharmaceutical Preparations